Abstract: A control method includes, in response to an electronic device entering a target mode, controlling at least two processing units to process display content for one or more display output areas to obtain processing results, and outputting the processing results to the one or more display output areas.

Abstract: The invention discloses a high strength fireproof board, which has two structures. The first structure is a three-layer hot pressed composite structure, which is composed of fiber layer, foaming fiber layer and fiber layer respectively from top to bottom, and the second structure is composed of hot-pressed fiber layer. The invention also discloses a wear resistant fireproof decorative panel consisting of a high strength fireproof board which is hot pressed at one time, or can be hot pressed twice, or composite molded after glue coated. The invention also discloses a manufacturing method for high strength fireproof board and wear resistant decorative panel based on high strength fireproof base board. The stated high strength fireproof board and wear resistant decorative panel are made of thermosetting resin and have the characteristics of flame retardant, wear resistant, high, and low temperature resistant, sound absorbing and antistatic.

Abstract: An electronic device. The electronic device includes a host having a first body and a second body, and a display screen rotatably connected to the host and configured to display to-be-output content output by the host, the display screen being rotatably connected to the host through the first body or the second body.

Abstract: An electronic device includes a first body, a second body, a connection device, and a bearing mechanism. The first body includes a support plane. The connection device is arranged at the support plane and is configured to connect the first body and the second body. The bearing mechanism is arranged at the first body. The connection device includes a plurality of connection members between the first body and the second body, and the second body rotates on the support plane through movements and rotations of the connection members in a plurality of slideways located on the support plane. The bearing mechanism is connected with the connection members and drives the connection members to move on the support plane to bear gravity of the second body.

Abstract: An electronic device. The electronic device includes a host having a first body and a second body, and a display screen rotatably connected to the host and configured to display to-be-output content output by the host, the display screen being rotatably connected to the host through the first body or the second body.

Abstract: An electronic device includes a first body, a second body, a connection device, and a bearing mechanism. The first body includes a support plane. The connection device is arranged at the support plane and is configured to connect the first body and the second body. The bearing mechanism is arranged at the first body. The connection device includes a plurality of connection members between the first body and the second body, and the second body rotates on the support plane through movements and rotations of the connection members in a plurality of slideways located on the support plane. The bearing mechanism is connected with the connection members and drives the connection members to move on the support plane to bear gravity of the second body.

Abstract: A method for acquiring information, an electric device and an identifier apparatus are described. The electronic device includes a wireless receiving apparatus capable of receiving information from a trigger object, and a display screen, the trigger object includes at least three surfaces each of which has a corresponding wireless communication apparatus. The method includes detecting trigger information from the wireless communication apparatus in the trigger object; determining a first surface among the at least three surfaces corresponding to the trigger information; acquiring first wireless RF information transmitted from the wireless communication apparatus corresponding to the first surface; and determining data information on the first surface corresponding to the first wireless RF information, according to the correspondence between wireless RF information and surface information.

Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.

Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug, solvate or hydrate thereof, wherein L, R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating abnormal cell growth, such as cancer in a mammal by administering the compounds of formula 1.

Abstract: The invention relates to compounds of formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R3, R4, R11, N, Z, A, m and p are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein X, L, R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.

Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein Q, A, L, R1, R2 and R3 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.

Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug, solvate or hydrate thereof, wherein L, R1, R2 R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating abnormal cell growth, such as cancer in a mammal by administering the compounds of formula 1.

Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein X, L, R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.

Abstract: Disclosed are 4-sulfide/sulfoxide/sulfonyl-1H-pyrazolyl derivative compounds of formulas (I) or (II): wherein the variables n, R, R1, R2, R3, R3?, R4, R4?, R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor.

Abstract: Disclosed are pyrazolyl derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formula (I) or (II): wherein the variables R, R1, R2, R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor.

Abstract: The invention relates to compounds of the formula 1 or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein Q, A, L, R1, R2 and R3 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.

Abstract: The invention relates to compounds of formula 1 1

Abstract: This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.

Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.